Evidence map›Paper›PMID 36517662›Full record

ArticleNeurocritical care2023

Substandard and Falsified Medications: A Barrier to Global Health Equity Exemplified in Ecuador.

Aleksandra Yakhkind, Adam Edward Lang, Gretchen Brophy, Eljim Tesoro, Kimberly E Levasseur-Franklin, Nelson Maldonado

Erratum issuedAbstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurocritical care, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Aleksandra YakhkindDepartment of Neurology, Tufts University School of Medicine, Boston, MA, USA.
Adam Edward LangDepartment of Primary Care, McDonald Army Health Center, Fort Eustis, VA, USA. a.edward.lang@gmail.com.ORCID 0000-0002-4347-6514
Gretchen BrophyDepartment of Pharmacotherapy and Outcomes Science, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, USA.
Eljim TesoroDepartment of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL, USA.
Kimberly E Levasseur-FranklinDepartment of Pharmacy, Tufts University Medical Center, Boston, MA, USA.
Nelson MaldonadoDepartment of Neurology, Universidad de San Francisco, Quito, Ecuador.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medicines have been developed and have become globalized at a pace faster than traditional medical education can keep up. Physicians, pharmacists, nurses, and advanced practice providers learn the names and functions of these medications, but not how they are made and how they get to the bedside. The often economically driven intricacies behind these processes have a dramatic effect on patient care and outcomes. A staggering proportion of medications worldwide are reported to be substandard or falsified. This article explores one country's story of how medication gets to the bedside, describes how this process can go wrong, and outlines what providers can do to work toward the goal of equitable access to quality medications for all.

Indexed as

Counterfeit DrugsPhysiciansEcuadorGlobal HealthHumansCounterfeit DrugsFalsified medicationsGlobal healthSubstandard medications

Identifiers

PMID36517662
PMCPMC9750049

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.